language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
TDOCTDOC

$7.225

-0.24
arrow_drop_down3.28%
Current Market·update13 Nov 2025 17:42
Day's Range
7.185-7.349
52-week Range
6.35-15.21

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-10-29
Next Earnings TimeAfter Market Close
Volume2.51M
Average Volume 30d7.17M

AI TDOC Summary

Powered by LiveAI
💰
-7.9
Valuation (P/E Ratio)
Valuation is negative due to losses.
📈
-0.57
EPS Growth (YoY)
Negative EPS growth
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Hold
65

The company exhibits mixed signals with strong fundamental and thematic aspects offset by negative technical indicators and a concerning profitability trend. A cautious approach is recommended.

Very Strong

Thematic

80

Teladoc Health operates in the growing telehealth and mental health sectors, benefiting from increasing adoption of virtual care and a focus on mental well-being.

Average

Fundamental

60

The company has a substantial debt burden and a history of net losses, although revenue has shown some growth. Profitability remains a significant concern.

Bearish

Technical

55

The stock is trading below key moving averages and shows weak momentum, indicating a bearish short-term outlook.

FactorScore
Virtual Healthcare Adoption90
Mental Health Services Demand85
Healthcare Digitization80
Competitive Landscape70
Reimbursement Policies75
FactorScore
Valuation60
Profitability10
Growth30
Balance Sheet Health40
Cash Flow70
FactorScore
Trend Analysis30
Momentum40
Volume Confirmation60
Support & Resistance70

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (7)

Financial Health & Liquidity chevron_right

Strong Cash Position

The company holds a substantial cash and cash equivalents of $1,298,327,000, providing significant financial flexibility.

Financial Health & Liquidity chevron_right

Positive Free Cash Flow

The company generated a positive free cash flow of $169,628,000 in the latest annual period, indicating strong cash generation after capital expenditures.

Show More 🔒
thumb_down

Bearish Points (8)

Profitability & Margins chevron_right

Significant Net Loss

The company reported a substantial net loss of -$1,001,245,000 in 2024 and -$13,659,531,000 in 2022, indicating significant profitability challenges.

Profitability & Margins chevron_right

Negative Net Margin

The net margin in 2024 was -39.0%, and in 2022 it was a highly negative -567.5%, signaling operational inefficiencies or pricing issues.

Show More 🔒

Calendar

July 2025

30

Next Earnings Date

EPS Est.
Revenue Est.

H: $-0.25

A: $-0.30

L: $-0.36

H: 626.71M

A: 621.91M

L: 605.75M

Profile

Employees (FY)4.62K
ISIN-
FIGI-

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Seasonals

2025
2024
2023
2022
2021

Price Target

8.97 USD

The 39 analysts offering 1 year price forecasts for TDOC have a max estimate of 12.00 and a min estimate of 7.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
165M (93.87%)
Closely held shares
10.7M (6.13%)
175M
Free Float shares
165M (93.87%)
Closely held shares
10.7M (6.13%)

Capital Structure

Market cap
1.44B
Debt
1.58B
Minority interest
0.00
Cash & equivalents
1.3B
Enterprise value
1.73B

Valuation - Summary

Market Cap
1.44B
Net income
-175M(-12.12%)
Revenue
1.91B(132.55%)
1.44B
Market Cap
1.44B
Net income
-175M(-12.12%)
Revenue
1.91B(132.55%)
Price to earning ratio (P/E)-8.20x
Price to sales ratio (P/S)0.80x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
2.57B
COGS
751.27M
Gross Profit
1.82B
OpEx
2.03B
Operating Income
-208.79M
Other & Taxes
792.46M
Net Income
-1B

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒